Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |